Epsilon M&A Deal Report - Lazeo
Transaction Multiples for the Valuation of Private Companies
Blackstone / Lazeo
No EMAT :
122390
Announced Date :
06/07/2023
Type :
Acquisition of Minority Stake
Deal Value :
Yes
Acquirer :
Blackstone
Target :
Lazeo
Country :
France
Sector of activity :
- Health Care Providers > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Clinics and hospitals
Business Description :
Lazeo is a French leader in aesthetic medical services, offering a wide range of non-invasive and minimally invasive treatments. Headquartered in Paris, the group operates a network of clinics...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
ns | |
| Current |
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Clinics and hospitals » = 126
| Date | Acquirer | Target | Country | Multiples | See details |
| 17/09/2021 | Grifols | Biotest | Germany | *** | 122311 |
| 02/08/2024 | Private Group led by 21 Invest | Rocamed SAM | Monaco | * | 122117 |
Source: Epsilon Research / EMAT
